Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aanika Biosciences
AddedFeb 15, 2024
UpdatedJul 17, 2026
Aanika Biosciences

Aanika Biosciences

Pre-Seed

Aanika Biosciences: Ensuring food security and supply chain integrity via synthetic biology.

HQ
New York, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded with a vision to enhance food security and supply chain integrity, Aanika Biosciences leverages synthetic biology to provide innovative solutions for large food and agricultural companies. Their core mission is to ensure the integrity of supply chains and reduce potential losses, thereby contributing to global food security. Aanika's products and services are designed to track and verify the origin and quality of food products, ensuring that consumers receive safe and authentic goods.

Notable figures associated with Aanika Biosciences include Vishaal Buyaan, who is recognized for his visionary leadership. The company has made significant strides in the synthetic biology sector, earning recognition for its contributions to food security. Through strategic partnerships and cutting-edge technology, Aanika has positively impacted the agricultural industry by enhancing transparency and trust within supply chains.

Aanika Biosciences - Similar Companies

Ansa Biotechnologies logo

Ansa Biotechnologies

ansabio.com

Antheia logo

Antheia

antheia.bio

Seedling Biosystems logo

Seedling Biosystems

seedling.bio

Think Bioscience logo

Think Bioscience

Twist Bioscience logo

Twist Bioscience

Bio-Nems logo

Bio-Nems

bio-nems.com

Anagenex logo

Anagenex

anagenex.com

DoubleRainbow Biosciences logo

DoubleRainbow Biosciences

InSyBio logo

InSyBio

insybio.gr

Alga Biosciences logo

Alga Biosciences

alga.bio

Bluestem Biosciences logo

Bluestem Biosciences

Synvivia logo

Synvivia

synvivia.com

Synlife logo

Synlife

synlifebio.com

Aureka Biotechnologies logo

Aureka Biotechnologies

aurekabio.com

Switch Bioworks logo

Switch Bioworks

switchbioworks.com

Aanika Biosciences - Quick Facts

Who are Aanika Biosciences' competitors?

Companies similar to Aanika Biosciences include Ansa Biotechnologies, Antheia, Seedling Biosystems and Think Bioscience.

When was Aanika Biosciences founded?

Aanika Biosciences was founded in 2018.

Where is Aanika Biosciences' headquarters located?

Aanika Biosciences' headquarters is located in New York, US.

When was Aanika Biosciences' last funding round?

Aanika Biosciences' most recent funding round was for $800k (USD) in May 2023.

How much has Aanika Biosciences raised to-date?

As of May 31, 2023, Aanika Biosciences has raised a total of $17M (USD).

How many employees does Aanika Biosciences have?

Aanika Biosciences has 15 employees as of Feb 4, 2024.

Aanika Biosciences - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
  • Synthetic Biology
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Food Security
Tags
  • AgTech
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software